Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences

The Alzheimer's Association and the National Institute on Aging sponsored a meeting of experts in Alzheimer's disease (AD), geneticists, social scientists, and ethicists in Chicago in October 1995 to discuss the use of apolipoprotein E (APOE) genotyping in Alzheimer's disease. A short scientific report was published in the scientific journal Lancet with recommendations from the group. Several areas were discussed, including: (1) the scientific basis for recommendations on the application and uses of APOE genotyping, (2) clarifying the clinical and epidemiological research that needs to done, (3) genetic counseling issues, (4) ethical and legal issues, and (5) potential uses of APOE genotyping for treatment care planning. This contribution was a general introduction to begin the meeting. The genetic association of APOE genotypes with the age of onset distribution and risk of Alzheimer's disease was reviewed. An analysis of the current applications for three distinctly different applications of APOE genotyping was presented with the following conclusions: (1) predictive testing for cognitively intact persons was not recommended; (2) APOE genotyping is a promising adjunct for use in the differential diagnosis of patients with dementia; and (3) APOE genotyping may have a use in selecting therapies; however, further prospective studies are necessary. There is no universal "APOE test for AD." A strong emphasis was made to avoid use of the term in making recommendations regarding APOE genotyping without specific reference to the type of application involved. The predictive testing of asymptomatic persons versus APOE genotyping as a diagnostic adjunct for symptomatic patients has been seriously confused in both the lay and clinical press. The former application is not recommended, but diagnostic usefulness early in clinical evaluations for dementia has been confirmed.

[1]  T. Jones,et al.  Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease , 1996, The Lancet.

[2]  M. Kawakami,et al.  A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease , 1993, Neuroscience Letters.

[3]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[4]  A. Roses,et al.  Avid Binding of βA Amyloid Peptide to Its Own Precursor , 1993, Experimental Neurology.

[5]  Ichiro Kanazawa,et al.  ApoE–ε4 and early–onset Alzheimer's , 1994, Nature Genetics.

[6]  A. Roses.  Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease , 1995, Annals of neurology.

[7]  T. Hänninen,et al.  Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study , 1994, BMJ.

[8]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[9]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[10]  S. Shimohama,et al.  Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[11]  M. Pericak-Vance,et al.  Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease , 1996, The Lancet.

[12]  T. Bird.  Apolipoprotein E genotyping in the diagnosis of alzheimer's disease: A cautionary view , 1995, Annals of neurology.

[13]  M. Pericak-Vance,et al.  Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.

[14]  B. Tycko,et al.  The apolipoprotein ε4 allele in patients with Alzheimer's disease , 1993, Annals of neurology.

[15]  N. Relkin,et al.  Apolipoprotein E genotyping in Alzheimer's disease , 1996, The Lancet.

[16]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[17]  G. Schellenberg,et al.  Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans , 1995, Annals of neurology.

[18]  C. Duijn,et al.  APOE genotyping in differential diagnosis of Alzheimer's disease , 1996, The Lancet.

[19]  J. Trojanowski,et al.  Apolipoprotein E ε4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan , 1994 .